Clinical Trials Logo

Clinical Trial Summary

The primary goal of this study is to retrospectively collect data on the safety and efficacy of Suturable DuraGen™.


Clinical Trial Description

This is a multicenter, non-randomized, non-interventional, retrospective Post-Market Clinical Follow-up (PMCF) study to evaluate the occurrence of post-operative cerebrospinal fluid (CSF) leaks within 30 days (and up to 90 days) after use of Suturable DuraGen™ for a supratentorial, infratentorial, or spinal procedure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04923867
Study type Observational
Source Integra LifeSciences Corporation
Contact
Status Active, not recruiting
Phase
Start date April 28, 2021
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT04057157 - Post-market Assessment of Biodesign Dural Repair Grafts
Withdrawn NCT02902133 - Acetazolamide to Prevent Post Operative CSF Leak Phase 2
Recruiting NCT02927782 - Mobilisation Algorithm After Incidental Durotomy N/A
Completed NCT03566602 - Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery N/A
Completed NCT02891070 - Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery Phase 3
Recruiting NCT04490629 - The Efficacy and Safety of a Latest Dural Substitute N/A
Withdrawn NCT04351061 - Acetazolamide for the Prevention of Post Operative CSF Leak Phase 2
Recruiting NCT04086550 - Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery N/A
Completed NCT02457546 - The EVICEL® Neurosurgery Phase III Study Phase 3
Completed NCT04145544 - A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair. N/A
Completed NCT04124523 - Perioperative CSF Leak Management - an Opinion Study
Withdrawn NCT03181464 - Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics Phase 4